GlassScriptPhysician profile
Eric M Hart
NPI 1942497243
$5,482.96
in general payments reported to CMS, 2019-2025
26 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $210 · 2021: $1,343 · 2022: $259 · 2023: $1,325 · 2024: $1,655 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,021 · Food and Beverage: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,020.58 |
| Food and Beverage | $1,381.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sioux Surgical INC | $2,483.95 | 2021-2024 | |
| Medical Device Business Services, INC. | $873.20 | 2023 | Na |
| Kerecis Limited | $415.09 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $362.32 | 2019-2025 | Grafix Pl, Pico, Stravix Pl |
| Stryker Corporation | $221.63 | 2020-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Omega |
| Depuy Synthes Sales INC. | $215.42 | 2019-2024 | Hammerlock |
| Organogenesis INC. | $212.98 | 2020-2025 | Puraply Wound Matrix, Puraply |
| Musculoskeletal Transplant Foundation INC. | $101.02 | 2020 | |
| Integra Lifesciences Corporation | $91.49 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Melinta Therapeutics, LLC | $73.18 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $56.08 | 2025 | |
| Boston Scientific Corporation | $40.84 | 2024 | |
| Janssen Pharmaceuticals, INC | $39.26 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.14 | 2019 | |
| Kci USA, INC. | $30.51 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $27.58 | 2025 | Novosorb Btm |
| Abbvie INC. | $27.32 | 2021-2025 | |
| Arthrex, INC. | $24.00 | 2024 | |
| Averitas Pharma INC. | $22.59 | 2023 | Qutenza |
| Ani Pharmaceuticals, INC. | $21.87 | 2025 | Purified Cortrophin Gel |
| Solventum Corporation | $21.85 | 2025 | V.A.C. Veraflo, Prevena |
| Osiris Therapeutics INC. | $21.17 | 2019 | |
| Bioventus LLC | $18.86 | 2020 | |
| Davol INC. | $16.26 | 2025 | Arista |
| Allergan, INC. | $16.15 | 2020 | |
| Rsw Medical Company, INC. | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.